The initial success of Viagra undeniably revolutionized the drug landscape, but betting in companies primarily reliant on generic versions presents a challenging picture. Although early profits were substantial, the end of patents and the rise of less expensive alternatives have weakened market share. Thus, a thorough assessment of present financia